Doctor of Medicine, Associate Professor, Chief Physician, Master's Supervisor. Specializes in interventional therapy, ablation, targeted immunotherapy and chemotherapy for primary liver cancer, cholangiocarcinoma and various metastatic liver cancers.Research Direction: Liver cancer stem cells and immune microenvironment. Academic Achievements: Has published more than 40 SCI papers in the field of liver cancer, among which 20 were published as the first author or corresponding author, with a cumulative impact factor of over 60. Multiple basic and clinical research projects have been presented at well‑known international liver cancer conferences including ILCA and APPLE. He has presided over or participated in numerous clinical studies on liver cancer, and the outcomes of his clinical research were accepted for poster presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting. As a principal investigator, he has obtained total research funding exceeding 2 million RMB, including 2 General Programs and 1 Young Scientist Program supported by the National Natural Science Foundation of China. He is a grantee of the Outstanding Backbone Program of Zhongshan Hospital, holds 4 patents, and has won the Third Prize of the "Tang Zhaoyou‑China Construction Bank Liver Cancer Diagnosis and Treatment Research Award".